The eye as a window to the pathophysiology in Parkinson's syndromes;Das Auge als Zugang zur Pathophysiologie von Parkinson-Syndromen

Nervenarzt

Volumn 84, Issue 8, 2013, Pages 909-917

  Kassubek, J ^a   Danek, A ^c   Del Tredici Braak, K ^a,b   Greenlee, M W ^d   Pinkhardt, E H ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Synuclein; Early diagnosis; Oculomotor system; Parkinson's disease; Pathophysiology

Indexed keywords

ARTICLE; COLOR VISION; DEPTH PERCEPTION; HUMAN; OCULOMOTOR SYSTEM; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PSYCHOLOGIC TEST;

DIAGNOSIS, DIFFERENTIAL; HUMANS; PARKINSONIAN DISORDERS; RETINAL DISEASES; SYMPTOM ASSESSMENT; VISION DISORDERS;

EID: 84884593923     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-013-3754-3     Document Type: Article

References (58)

1. Winkler J, Ehret R, Büttner T et al (2011) Parkinson's disease risk score: moving to a premotor diagnosis. J Neurol 258(Suppl 2):311-315
2. Surguchov A, McMahan B, Masliah E, Surgucheva I (2001) Synucleins in ocular tissues. J Neurosci Res 65:68-77
3. Martínez-Navarrete GC, Martín-Nieto J, Esteve-Rudd J et al (2007) Alpha synuclein gene expression profile in the retina of vertebrates. Mol Vis 13:949-961
4. Leger F, Fernagut P-O, Canron M-H et al (2011) Protein aggregation in the aging retina. J Neuropathol Exp Neurol 70:63-68
5. Rüb U, Del Tredici K, Schultz C et al (2001) The premotor region essential for rapid vertical eye movements shows early involvement in Alzheimer's disease-related cytoskeletal pathology. Vision Res 41:2149-2156
6. Jones RD, Donaldson IM, Timmings PL (1992) Impairment of high-contrast visual acuity in Parkinson's disease. Mov Disord 7:232-238
7. Diederich NJ, Raman R, Leurgans S, Goetz CG (2002) Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol 59:1249-1252
8. Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson's disease. Brain 132:1128-1145
9. Bodis-Wollner I (2009) Retinopathy in Parkinson Disease. J Neural Transm 116:1493-1501
10. Bodis-Wollner I (2013) Foveal vision is impaired in Parkinson's disease. Parkinsonism Relat Disord 19:1-14
11. Tebartz van Elst L, Greenlee MW, Foley JM, Lucking CH (1997) Contrast detection, discrimination and adaptation in patients with Parkinson's disease and multiple system atrophy. Brain 120:2219-2228
12. Hunter S (1985) The rostral mesencephalon in Parkinson's disease and Alzheimer's disease. Acta Neuropathol 68:53-58
13. Arai K, Kato N, Kashiwado K, Hattori T (2000) Pure autonomic failure in association with human alpha-synucleinopathy. Neurosci Lett 296:171-173
14. Hartog Jager den WA, Betlehem J (1960) The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:283-290
15. Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol 119:703-713
16. Bodis-Wollner I, Yahr MD (1978) Measurements of visual evoked potentials in Parkinson's disease. Brain 101:661-671
17. Ikeda H, Head GM, Ellis CJ (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res 34:2629-2638
18. Bodis-Wollner I, Marx MS, Mitra S et al (1987) Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 110: 1675-1698
19. Marx M, Bodis-Wollner I, Bobak P et al (1986) Temporal frequency-dependent VEP changes in Parkinson's disease. Vision Res 26:185-193
20. Oh YS, Kim JS, Chung SW et al (2011) Color vision in Parkinson's disease and essential tremor. Eur J Neurol 18:577-583
21. Bulens C, Meerwaldt JD, Van der Wildt GJ, Van Deursen JB (1987) Effect of levodopa treatment on contrast sensitivity in Parkinson's disease. Ann Neurol 22:365-369
22. Bodis-Wollner I (1990) Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci 13:296-302
23. Dowling JE, Ehinger B (1975) Synaptic organization of the amine-containing interplexiform cells of the goldfish and Cebus monkey retinas. Science 188:270-273
24. Frederick JM, Rayborn ME, Laties AM et al (1982) Dopaminergic neurons in the human retina. J Comp Neurol 210:65-79
25. Papadopoulos GC, Parnavelas JG (1990) Distribution and synaptic organization of dopaminergic axons in the lateral geniculate nucleus of the rat. J Comp Neurol 294:356-361
26. Reader TA, Quesney LF (1986) Dopamine in the visual cortex of the cat. Experientia 42:1242-1244
27. Regan D, Maxner C (1987) Orientation-selective visual loss in patients with Parkinson's disease. Brain 110:415-432
28. Lieb K, Brucker S, Bach M et al (1999) Impairment in preattentive visual processing in patients with Parkinson's disease. Brain 122:303-313
29. Stebbins GT, Goetz CG, Carrillo MC et al (2004) Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 63:1409-1416
30. Meppelink AM, Jong BM de, Renken R et al (2009) Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 132:2980-2993
31. Diederich NJ, Fénelon G, Stebbins G (2009) Hallucinations in Parkinson disease. Nat Rev Neurol 5:331-342
32. Gibson G, Mottram PG, Burn DJ et al (2012) Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study. Int J Geriatr Psychiatry. doi:10.1002/gps.3869 (online first)
33. Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov Disord 26:2387-2395
34. Mosimann UP, Collerton D, Dudley R et al (2008) A semi-structured interview to assess visual hallucinations in older people. Int J Geriatr Psychiatry 23:712-718
35. Papapetropoulos S, Katzen H, Schrag A et al (2008) A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease. BMC Neurol 8:21
36. Williams DR, Warren JD, Lees AJ (2008) Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry 79:652-655
37. Fénelon G, Soulas T, Cleret de Langavant L et al (2011) Feeling of presence in Parkinson's disease. J Neurol Neurosurg Psychiatry 82:1219-1224
38. Janzen J, Ent D van 't, Lemstra AW et al (2012) The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study. J Neurol 259:147-154
39. Bertram K, Williams DR (2012) Visual hallucinations in the differential diagnosis of parkinsonism. J Neurol Neurosurg Psychiatry 83:448-452
40. Miller DT, Kocaoglu OP, Wang Q, Lee S (2011) Adaptive optics and the eye (super resolution OCT). Eye (Lond) 25:321-330
41. Altintas O, Iseri P, Ozkan B, Caglar Y (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 116:137-146
42. Aaker GD, Myung JS, Ehrlich JR et al (2010) Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 4:1427-1432
43. Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord 17:431-436
44. Spund B, Ding Y, Liu T et al (2012) Remodeling of the fovea in Parkinson disease. J Neural Transm (in press) doi:10.1007/s00702-012-0909-5
45. Albrecht P, Muller AK, Sudmeyer M et al (2012) Optical coherence tomography in parkinsonian syndromes. PLoS ONE 7:e34891
46. Fischer MD, Synofzik M, Heidlauf R et al (2011) Retinal nerve fiber layer loss in multiple system atrophy. Mov Disord 26:914-916
47. Ho W-L, Leung Y, Tsang AW-T et al (2012) Review: tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain? Mol Vis 18:2700-2710
48. Pinkhardt EH, Kassubek J (2011) Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism Relat Disord 17:223-230
49. Pinkhardt EH, Kassubek J (2011) Untersuchung der Okulomotorik als differenzialdiagnostisches Instrument bei Parkinson-Syndromen. Nervenheilkunde 30:259-262
50. Vidailhet M, Rivaud S, Gouider-Khouja N et al (1994) Eye movements in parkinsonian syndromes. Ann Neurol 35:420-426
51. Chan F, Armstrong IT, Pari G et al (2005) Deficits in saccadic eye-movement control in Parkinson's disease. Neuropsychologia 43:784-796
52. Kimmig H, Haussmann K, Mergner T, Lucking CH (2002) What is pathological with gaze shift fragmentation in Parkinson's disease? J Neurol 249:683-692
53. Blekher T, Weaver M, Rupp J et al (2009) Multiple step pattern as a biomarker in Parkinson disease. Parkinsonism Relat Disord 15:506-510
54. Armstrong IT, Chan F, Riopelle RJ, Munoz DP (2002) Control of saccades in Parkinson's disease. Brain Cogn 49:198-201
55. Gorges M, Müller HP, Lulé D et al (2013) Functional connectivity within the default mode network is associated with saccadic accuracy in Parkinson's disease: a resting state fMRI and videooculographic study. Brain Connect. DOI 10.1089/brain.2013.0146
56. Pinkhardt EH, Jürgens R, Lulé D et al (2012) Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms. BMC Neurol 12:5
57. Pinkhardt EH, Jürgens R, Becker W et al (2008) Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease. J Neurol 255:1916-1925
58. Chen AL, Riley DE, King SA et al (2010) The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Front Neurol 1:147